Butler John P.'s Form 4 filing
Akebia Therapeutics, Inc. (AKBA) · filed Feb 4, 2026
- Accession no.
- 0001591467-26-000002
- Filed
- Feb 4, 2026
- Trade date
- Feb 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $474.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butler John P.CIK 0001591467 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | SSaleDisposed | −46,660 | $1.39 | −$64,857.4 | 3,417,189 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −96,065 | $1.39 | −$133,530.35 | 3,321,124 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −114,891 | $1.39 | −$159,698.49 | 3,206,233 | Direct | |
| Feb 2, 2026 | Common Stock | AGrant or awardAcquired | +175,250 | $1.41 | +$247,102.5 | 3,381,483 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −83,689 | $1.39 | −$116,327.71 | 3,297,794 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.